GLP-1 RA therapy in addition to standard hypoglycemic drugs vs. standard hypoglycemic drugs may significantly reduce inflammation, and BNP values in failing heart patients with diabetes treated by CRTd. The gene discussed is GLP1R; the disease is diabetes mellitus.